The National  Memo Logo

Smart. Sharp. Funny. Fearless.

Monday, December 09, 2019 {{ new Date().getDay() }}

Reprinted with permission from Alternet

President Donald Trump has relentlessly promoted the anti-malaria drug hydroxychloroquine as a possible treatment for COVID-19 — and many health experts have been warning that not only is there no evidence it could prevent COVID-19, but also, that it could have dangerous side effects. Now, the World Health Organization, according to The Independent, has announced the suspension of its clinical trial for hydroxychloroquine.


WHO Director General Tedros Adhanom Ghebreyesus announced, "The executive group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity trial while the safety data is reviewed by the data safety monitoring board. The other arms of the trial are continuing."

WHO's decision follows a study published in the medical journal The Lancet, which found that use of hydroxychloroquine increases the risk of death by 34 percent and serious heart arrhythmias by 137%. The authors of The Lancet's study explained, "Our large-scale, international, real-world analysis supports the absence of a clinical benefit of chloroquine and hydroxychloroquine and points to potential harm in hospitalized patients with COVID-19."

Another warning about the possible dangers of hydroxychloroquine came from the Food and Drug Administration — which, in late April, warned, "Hydroxychloroquine and chloroquine have not been shown to be safe and effective for treating or preventing COVID-19. They are being studied in clinical trials for COVID-19, and we authorized their temporary use during the COVID-19 pandemic for treatment of the virus in hospitalized patients when clinical trials are not available."

Start your day with National Memo Newsletter

Know first.

The opinions that matter. Delivered to your inbox every morning

US Speaker of the House Nancy Pelosi wants her Democrats to push through trillions of dollars worth of investments in infrastructure and social service programs before a self-imposed deadline of September 30, 2021

Washington (AFP) - House Speaker Nancy Pelosi expressed confidence a massive infrastructure bill will pass this week but acknowledged it would not get a Monday vote as planned, with fellow Democrats warning critical work remains to meet the party's deadlines.

Democrats have been scrambling to hammer out a landmark plan to upgrade the nation's roads and bridges, but are also under immense pressure to finalize a $3.5 trillion public investment package and fund the government to avert a looming shutdown -- all by September 30.

Keep reading... Show less
x
{{ post.roar_specific_data.api_data.analytics }}